Clinical Trial Update: A Study Comparing the Effects of Trimbow to Fostair in COPD [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Trimbow to Fostair in COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fostair
• Trimbow (budesonide/formoterol/glycopyrronium)

Snippet

Sponsor: Medicines Evaluation Unit Ltd | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: COMPLETED